Principal Investigator
Justin Watts
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20221233
Clinical Trial Summary
Safety and Efficacy of Venetoclax and Azacitidine for Newly Diagnosed Non-Elderly Adult Patients (aged 18-59) with Acute Myeloid Leukemia
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Leukemia/heme
Contact Information
Phone Number
305-243-2647